Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intestinal epithelial cell proliferation is the process by which new cells are generated within the lining of the intestine. This highly dynamic and tightly regulated process is essential for maintaining intestinal homeostasis, supporting nutrient absorption, and providing a barrier against pathogens. The proliferative compartment is located at the base of crypts where intestinal stem cells divide to produce transient amplifying progenitor cells which then differentiate into mature epithelial lineages. Proliferation is controlled by Wnt/β-catenin signaling, EGF signaling, TGF-alpha/beta peptides, nutrient sensing, and microbiome influence. Dysregulation can lead to insufficient renewal (barrier dysfunction) or excessive proliferation (neoplasia).
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intestinal Epithelial Cell Proliferation (IEC Proliferation).